BioRem Balance Sheet Health

Financial Health criteria checks 5/6

BioRem has a total shareholder equity of CA$4.5M and total debt of CA$3.1M, which brings its debt-to-equity ratio to 69.2%. Its total assets and total liabilities are CA$17.6M and CA$13.1M respectively. BioRem's EBIT is CA$1.4M making its interest coverage ratio 6.1. It has cash and short-term investments of CA$2.4M.

Key information

69.2%

Debt to equity ratio

CA$3.11m

Debt

Interest coverage ratio6.1x
CashCA$2.38m
EquityCA$4.49m
Total liabilitiesCA$13.13m
Total assetsCA$17.62m

Recent financial health updates

Recent updates

BioRem (CVE:BRM) Has A Pretty Healthy Balance Sheet

Jan 25
BioRem (CVE:BRM) Has A Pretty Healthy Balance Sheet

Is BioRem (CVE:BRM) Using Too Much Debt?

Aug 26
Is BioRem (CVE:BRM) Using Too Much Debt?

Here's Why BioRem (CVE:BRM) Can Manage Its Debt Responsibly

Mar 23
Here's Why BioRem (CVE:BRM) Can Manage Its Debt Responsibly

BioRem (CVE:BRM) Could Easily Take On More Debt

Aug 25
BioRem (CVE:BRM) Could Easily Take On More Debt

These 4 Measures Indicate That BIOREM (CVE:BRM) Is Using Debt Reasonably Well

May 20
These 4 Measures Indicate That BIOREM (CVE:BRM) Is Using Debt Reasonably Well

Here's What's Concerning About BIOREM's (CVE:BRM) Returns On Capital

Jan 26
Here's What's Concerning About BIOREM's (CVE:BRM) Returns On Capital

Key Things To Understand About BIOREM's (CVE:BRM) CEO Pay Cheque

Nov 23
Key Things To Understand About BIOREM's (CVE:BRM) CEO Pay Cheque

Financial Position Analysis

Short Term Liabilities: BRM's short term assets (CA$14.1M) exceed its short term liabilities (CA$10.4M).

Long Term Liabilities: BRM's short term assets (CA$14.1M) exceed its long term liabilities (CA$2.8M).


Debt to Equity History and Analysis

Debt Level: BRM's net debt to equity ratio (16.2%) is considered satisfactory.

Reducing Debt: BRM's debt to equity ratio has increased from 0% to 69.2% over the past 5 years.

Debt Coverage: BRM's debt is well covered by operating cash flow (101.6%).

Interest Coverage: BRM's interest payments on its debt are well covered by EBIT (6.1x coverage).


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.